OM
Outset Medical Inc.
Company Overview
| Mkt Cap | $257.08M | Price | $3.29 |
| Volume | 283.05K | Change | -0.90% |
| P/E Ratio | -2.0 | Open | $3.33 |
| Revenue | $113.7M | Prev Close | $3.32 |
| Net Income | $-128.0M | 52W Range | $3.59 - $25.35 |
| Div Yield | N/A | Target | $13.25 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 41 |
No chart data available
About Outset Medical Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Latest News
Toho Holdings Rejects Activist’s Call for New Probe Into Past Antitrust Violations
SIA Engineering Reshapes Board and Committees to Strengthen Governance and Oversight
Wilton Resources Flags Release of Subsidiary’s 9M 2025 Results and Sets Timeline for Group Accounts
EPF Adjusts Substantial Shareholding Position in IHH Healthcare
Lincotrade Secures JTC Lease Extension to Support Transition to New Tuas Facility
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OM | $3.29 | -0.9% | 283.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |